TCH GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
S.Con.Res.11-An original concurrent resolution setting forth the congressional budget for the United States government for fiscal year 2016.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Health Issues HCR
General heath care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative regulatory issues. 340B Drug Discount Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Medicare/Medicaid MMM
Medicare Part D issues. S.31 Medicare Prescription Drug Price Negotiation Act- Provisions related to Part D program. S.141 Protecting Seniors Access to Medicare Act of 2015. H.R. 1470 SGR Repeal and Medicare Provider Payment Modernization Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.